Academic literature on the topic 'Psoriasis, T helper 17 cells, biologic therapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Psoriasis, T helper 17 cells, biologic therapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Psoriasis, T helper 17 cells, biologic therapy"
Kandalova, Olga В., Dina E. Klyuchnikova, and Tatyana V. Ayvazova. "Pathogenesis of psoriasis: past, present, future." Russian Journal of Skin and Venereal Diseases 25, no. 3 (October 13, 2022): 191–200. http://dx.doi.org/10.17816/dv108870.
Full textSatoh, Y., K. Nakano, H. Yoshinari, S. Nakayamada, S. Iwata, S. Kubo, I. Miyagawa, et al. "A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab." Lupus 27, no. 7 (March 9, 2018): 1202–6. http://dx.doi.org/10.1177/0961203318762598.
Full textZhukova, O. V., E. I. Kasikhina, M. N. Ostretsova, and N. N. Potekaev. "New possibilities of systemic therapy of plaque psoriasis with the IL23p19 inhibitor risankizumab." Meditsinskiy sovet = Medical Council, no. 8 (June 7, 2021): 40–50. http://dx.doi.org/10.21518/2079-701x-2021-8-40-50.
Full textFlores, Rodrigo, Raúl de la Fuente, Francisca Bozán, Karen Vergara, and Fernando Valenzuela. "Actualización en terapia biológica para psoriasis y artritis psoriática (parte I): moléculas pequeñas, inhibidores de JAK y agentes biológicos (inhibidores IL-17)." Latin american journal of clinical sciences and medical technology 2, no. 2 (July 15, 2020): 113–25. http://dx.doi.org/10.34141/ljcs6065977.
Full textRoy, Amit Kumar, Fahad Al Basir, Priti Kumar Roy, and Amar Nath Chatterjee. "A model analysis to measure the adherence of Etanercept and Fezakinumab therapy for the treatment of psoriasis." Nonlinear Analysis: Modelling and Control 27 (March 16, 2022): 1–21. http://dx.doi.org/10.15388/namc.2022.27.26483.
Full textBaker, Kenneth F., and John D. Isaacs. "Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?" Annals of the Rheumatic Diseases 77, no. 2 (August 1, 2017): 175–87. http://dx.doi.org/10.1136/annrheumdis-2017-211555.
Full textChristoforou, T., G. Almanzar, F. Brauneiser, N. Buschmann, M. Feuchtenberger, M. Schmalzing, H. P. Tony, M. Goebeler, and M. Prelog. "AB0040 IMPAIRED REGULATORY T CELL FUNCTIONS IN PATIENTS WITH PSORIASIS ARTHRITIS ELIGIBLE TO SWITCH TO ANTI-IL-17 TREATMENT." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1322.2–1323. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6389.
Full textAhmed Shaheen, Aciel, Ismail Hader, and Zakaria Aqel. "Novel Presentation of Terminal Ileitis Associated with Secukinumab Therapy." Case Reports in Gastrointestinal Medicine 2021 (September 28, 2021): 1–4. http://dx.doi.org/10.1155/2021/5213876.
Full textVojdani, Aristo, and Jama Lambert. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I." Evidence-Based Complementary and Alternative Medicine 2011 (2011): 1–8. http://dx.doi.org/10.1093/ecam/nep062.
Full textPithadia, Deeti J., Kelly A. Reynolds, Erica B. Lee, Wilson Liao, and Jashin J. Wu. "Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy." Therapeutic Advances in Chronic Disease 10 (January 2019): 204062231986565. http://dx.doi.org/10.1177/2040622319865658.
Full textDissertations / Theses on the topic "Psoriasis, T helper 17 cells, biologic therapy"
ANTIGA, EMILIANO. "Ruolo dei linfociti Th17 e dei loro precursori in pazienti con psoriasi volgare prima e dopoil trattamento con farmaci biologici." Doctoral thesis, 2012. http://hdl.handle.net/2158/649269.
Full text